Highlights a study on S-adenosyl-L-methionine (SAMe) for treatment of depression, osteoarthritis and liver disease. Models used in meta-analyses; Effectiveness of SAMe for depression, osteoarthritis and liver disease; Categorization of SAMe which deprives it both of the attention and the regulation it warrants.